Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-02-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于注销股权激励计划第二个行权期股票期权的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the cancellation of stock options granted under an equity incentive plan. It details the board meetings, decisions, and legal opinions related to the cancellation of stock options for certain employees due to performance issues. The document includes specifics about the number of options cancelled, the reasons for cancellation, and the impact on the company. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement about a corporate action related to stock options. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about a corporate governance matter that does not fit into more specific categories like Board/Management Information or Share Issue/Capital Change. The document is over 6,000 characters and contains detailed information, but it is not a financial report or a proxy statement. Therefore, the best classification is Regulatory Filings (RNS).
2015-02-12 Chinese
北京国枫律师事务所关于公司股票期权与限制性股票激励计划第二个行权期股票期权注销相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the cancellation of stock options under a stock option and restricted stock incentive plan for a specific company. It discusses legal compliance, procedures, and approvals related to the stock option cancellation. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of a report but a legal opinion on a corporate action related to stock options. This type of document fits best under the category of Regulatory Filings (RNS), as it is a compliance/legal document related to corporate governance and stock incentive plans, not a financial report or management announcement.
2015-02-12 Chinese
独立董事关于第二届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of SanNuo Bio-sensing Co., Ltd. regarding matters discussed at the 18th meeting of the second board of directors held on February 12, 2015. It references the company's 2014 financial performance and discusses the cancellation of stock options for certain incentive recipients based on performance assessments. The document cites relevant laws and regulations concerning independent directors and stock option incentive plans. The content focuses on board-level decisions and opinions related to management and governance matters, specifically about stock option incentives and their compliance with regulations. There is no detailed financial statement or comprehensive financial report, nor is it a simple announcement or certification. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management, including matters related to stock option plans and governance decisions by the board.
2015-02-12 Chinese
第二届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 18th meeting of the second board of directors of the company. It details the approval of a proposal related to the cancellation of stock options under the company's equity incentive plan. The document includes voting results and mentions legal opinions but does not contain financial statements or detailed financial analysis. It is a formal announcement of board decisions rather than a full management report or financial report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2015-02-12 Chinese
第二届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company 三诺生物传感股份有限公司. It details the decision to cancel certain stock options due to performance not meeting targets. The document includes voting results and procedural compliance statements. It is not a full financial report, audit report, or earnings release. It is also not a notice of dividend, capital change, or management change. The document is a formal announcement of a board meeting resolution, specifically from the Supervisory Board, which fits best under the category of Board/Management Information (MANG). The document length is short (1191 characters), and it contains substantive content about board decisions rather than just announcing a report publication or regulatory filing. Therefore, the classification is MANG with high confidence.
2015-02-12 Chinese
关于终止与华广生技股份有限公司《战略合作框架协议书》和《私募认股协议书》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the termination of previously signed strategic cooperation and private placement agreements between the company and another entity. It details the background of the agreements, reasons for termination, and the impact on the company. There are no financial statements, no detailed financial performance data, no management discussion of results, nor is it a report or presentation. The document is a formal announcement of a corporate event related to cooperation agreements and investment projects. It does not fit categories like Annual Report, Interim Report, Earnings Release, or M&A filings. It is not a regulatory certification or officer attestation. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2015-02-09 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.